Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China
· Delayed Price · Currency is CNY 22.42
-0.50 (-2.18%)
Apr 24, 2025, 2:45 PM CST
SHA:688298 Market Cap
SHA:688298 has a market cap or net worth of 4.43 billion as of April 23, 2025. Its market cap has decreased by -28.31% in one year.
Market Cap
4.43B
Enterprise Value
1.46B
Revenue
826.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.42
Market Cap Chart
Since February 5, 2020, SHA:688298's market cap has decreased from 17.52B to 4.43B, a decrease of -74.72%. That is a compound annual growth rate of -23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 4.43B | -21.85% |
| Dec 31, 2024 | 5.67B | -21.40% |
| Dec 29, 2023 | 7.21B | -44.35% |
| Dec 30, 2022 | 12.95B | -53.17% |
| Dec 31, 2021 | 27.66B | 13.55% |
| Dec 31, 2020 | 24.36B | 39.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.65B |
| Shenzhen Mindray Bio-Medical Electronics | 261.25B |
| WuXi AppTec | 153.68B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.28B |
| Aier Eye Hospital Group | 119.65B |
| Shanghai United Imaging Healthcare | 105.56B |
| Sichuan Biokin Pharmaceutical | 104.93B |
| Yunnan Baiyao Group Co.,Ltd | 102.51B |